Asset Details
Do you wish to reserve the book?
Lactoferrin’s Anti-Cancer Properties: Safety, Selectivity, and Wide Range of Action
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Lactoferrin’s Anti-Cancer Properties: Safety, Selectivity, and Wide Range of Action
Do you wish to request the book?
Lactoferrin’s Anti-Cancer Properties: Safety, Selectivity, and Wide Range of Action
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Lactoferrin’s Anti-Cancer Properties: Safety, Selectivity, and Wide Range of Action
2020
Overview
Despite recent advances in cancer therapy, current treatments, including radiotherapy, chemotherapy, and immunotherapy, although beneficial, present attendant side effects and long-term sequelae, usually more or less affecting quality of life of the patients. Indeed, except for most of the immunotherapeutic agents, the complete lack of selectivity between normal and cancer cells for radio- and chemotherapy can make them potential antagonists of the host anti-cancer self-defense over time. Recently, the use of nutraceuticals as natural compounds corroborating anti-cancer standard therapy is emerging as a promising tool for their relative abundance, bioavailability, safety, low-cost effectiveness, and immuno-compatibility with the host. In this review, we outlined the anti-cancer properties of Lactoferrin (Lf), an iron-binding glycoprotein of the innate immune defense. Lf shows high bioavailability after oral administration, high selectivity toward cancer cells, and a wide range of molecular targets controlling tumor proliferation, survival, migration, invasion, and metastasization. Of note, Lf is able to promote or inhibit cell proliferation and migration depending on whether it acts upon normal or cancerous cells, respectively. Importantly, Lf administration is highly tolerated and does not present significant adverse effects. Moreover, Lf can prevent development or inhibit cancer growth by boosting adaptive immune response. Finally, Lf was recently found to be an ideal carrier for chemotherapeutics, even for the treatment of brain tumors due to its ability to cross the blood–brain barrier, thus globally appearing as a promising tool for cancer prevention and treatment, especially in combination therapies.
Publisher
MDPI AG,MDPI
Subject
/ Adaptive Immunity - drug effects
/ Antineoplastic Agents - pharmacokinetics
/ Antineoplastic Agents - therapeutic use
/ Blood-Brain Barrier - immunology
/ Brain Neoplasms - drug therapy
/ Brain Neoplasms - immunology
/ Cancer
/ Drug Carriers - pharmacokinetics
/ Drug Carriers - therapeutic use
/ epithelial to mesenchymal transition
/ Functional foods & nutraceuticals
/ Humans
/ Iron
/ Lactoferrin - pharmacokinetics
/ Lactoferrin - therapeutic use
/ Ligands
/ Proteins
/ Review
